ADPT — Adaptive Biotechnologies Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual balance sheet for Adaptive Biotechnologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	688	353	498	346	222
Net Total Accounts Receivable
Net Total Receivables	12.5	18.8	40.9	39	43
Total Inventory
Prepaid Expenses
Total Current Assets	727	403	562	410	284
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	139	173	164	120	94.4
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,116	923	857	661	539
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	105	114	110	88	98.1
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	373	319	392	353	337
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	743	604	464	308	203
Total Liabilities & Shareholders' Equity	1,116	923	857	661	539
Total Common Shares Outstanding